Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia

NCT00003991 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: aldesleukin
DRUG: histamine dihydrochloride

Sponsor

Maxim Pharmaceuticals